Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02196 FOSUN PHARMA
RT Nominal down16.500 -0.060 (-0.362%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others22,768,1970.385%22,680,93222,202,92720,846,45815,718,789
Land & other Lease Assets4,967,072-2.096%5,073,3854,691,2714,248,0802,837,229
Intangible Assets30,626,7486.598%28,730,94128,139,95326,153,78724,288,678
Interests in Asso. & JCEs28,483,1588.164%26,333,24824,653,12423,881,02323,094,055
Other Non-current Assets3,745,00210.917%3,376,4143,243,8554,509,3105,895,262

90,590,1775.099%86,194,92082,931,13079,638,65871,834,013
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Inventories5,969,033-4.533%6,252,4727,258,6497,537,7686,882,432
Trade Receivables9,686,7802.757%9,426,8908,024,4337,668,2297,612,942
Cash & Bank Balances13,618,6483.926%13,104,22913,523,93313,693,59116,241,313
Other Current Assets5,524,8879.684%5,037,0815,609,0774,892,9814,122,912
Assets Held for Sale0--074,9680419,578

34,799,3482.894%33,820,67234,491,06033,792,56935,279,177
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Trade Payables5,024,757-2.318%5,144,0145,997,3856,159,6196,284,041
S-T Debt & Leases23,137,6697.711%21,481,32122,999,77319,433,26717,214,877
Other Current Liabilities10,433,5006.475%9,798,9828,455,5118,164,6959,799,152
Liab asso w/ Assets Held for Sale0--0000

38,595,9265.962%36,424,31737,452,66933,757,58133,298,070
Net Current Assets(3,796,578)45.818%(2,603,645)(2,961,609)34,9881,981,107
Total Assets Less Current Liabilities86,793,5993.831%83,591,27579,969,52179,673,64673,815,120
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
L-T Debt & Leases15,894,5406.583%14,912,76112,985,46815,554,51212,844,860
Other Non-current Liabilities7,535,5149.583%6,876,5407,088,7017,541,2496,912,067

23,430,0547.530%21,789,30120,074,16923,095,76119,756,927
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
  Share Capital2,670,4290.000%2,670,4292,671,3262,672,3992,672,157
  Reserves46,022,388-0.022%46,032,70344,551,40442,973,98741,859,584
  Others0--0000
Shareholders' Funds48,692,817-0.021%48,703,13247,222,73045,646,38644,531,741
Non-controlling Interests14,670,72812.000%13,098,84212,672,62210,931,4999,526,452
Others0--0000

63,363,5452.527%61,801,97459,895,35256,577,88554,058,193
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Commitments----3,770,1763,331,1064,282,7986,469,843
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 28/08/2026 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 1,721,468
%Change1.146%
EPS / (LPS)RMB 0.650
NBV Per Share (¥)RMB 18.447
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.